TEMPE, Ariz. – Intrinsic Bioprobes Inc. (“IBI”) today announced the launch of its first mass spectrometry-based protein assays for in-vitro diagnostic testing. The assays for beta-2-microglobulin, cystatin C, and retinol binding protein are performed on IBI’s MASSAY® platform at the CLIA-certified and College of American Pathology (CAP) accredited diagnostic laboratory of the Institute of Genomics […]
Washington, D.C. – Danaher Corporation (NYSE:DHR) announced today that its previously announced tender offer to acquire all of the outstanding shares of Beckman Coulter, Inc. (NYSE: BEC) for $83.50 per share in cash (“the Offer”) has been extended and will now expire at 12:00 midnight, New York City time, at the end of June 6, […]
Dortmund – Protagen AG today announced that Scienion AG will produce protein microarray batches for the clinical validation of the proprietary biomarker panels of Protagen. The batch sizes will comprise more than 1000 arrays. Additionally, both companies plan to jointly evaluate new platforms for multiplex analytics and to co-develop novel approaches up to proof-of concept […]
Santa Fe Springs, Calif. – Applied BioCode Inc. and EraGen Biosciences Inc. today announced that they have entered into a strategic partnership and license agreement. The agreement provides EraGen with access to Applied BioCode’s Barcoded Magnetic Bead technology and the BioCode 1000 analyzer. This technology provides a robust and reliable solution for development and clinical […]
NORTHBROOK, Ill. – Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today it has initiated commercial launch in Europe. Nanosphere received CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its Respiratory Virus Plus Nucleic Acid Test, CYP 2C19 Nucleic Acid Test […]
Constance, Germany – At the moment, the only reliable way of diagnosing chromosomal irregularities during pregnancy is to use invasive prenatal methods. This causes miscarriage in about one per cent of these risky surgical procedures. Scientists from the Center for Prenatal Diagnosis and Human Genetics, Kudamm-199, in Berlin have been working with scientists from GATC […]
OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) announced today that it has launched kits for high sensitivity mutational analysis of the BRAF and PIK3CA genes. These new kits complement the company’s existing kits for detecting mutations in K-RAS, expanding Transgenomic’s range of its proprietary SURVEYOR Scan mutation detection kit product line. Mutations in all three […]
CHELMSFORD, Massachusetts – Magellan Biosciences, a global manufacturer of products designed to make diagnostic testing easier, more cost-effective, and less labor intensive, today announced an agreement with Bruker Corporation (NASDAQ: BRKR) to deliver microbial identification from cultures using MALDI-TOF proteomic finger-printing, along with Magellan’s TREK-brand susceptibility tests to clinical, research, and veterinary laboratory customers. The […]
CHICAGO – Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care, announced today that Scott Garrett has joined the firm as an operating partner. Mr. Garrett, 61, the former chairman, president and chief executive officer of Beckman Coulter, Inc., brings to Water Street more than 35 years of experience leading […]
SUNNYVALE, Calif. – Cepheid (Nasdaq: CPHD) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Xpert® C. difficile/Epi test. Cepheid’s first Xpert C. difficile test has been available in the United States since July 2009. The test’s unique combination of high sensitivity and rapid turnaround time […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
